This page lists all known medications that could potentially lead to 'Vascular calcification' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Collaboration aims to accelerate the development of treatments for chronic kidney disease (CKD) and other conditions Rectify has developed oral, ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of cardiovascular death worldwide—in large mammals, a study suggests. Real-time ...

Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program.

Absence of muscle tissue in biopsy samples is common and associated with increased risk of death. In a small study, 50% of non-diabetic hemodialysis patients with elevated FGF-23 showed correlations ...

Heart disease and stroke are the world's two most deadly diseases, causing over 15 million deaths in 2016 according to the World Health Organization. A key underlying factor in both of these global ...

In the hemodialysis population, cardiovascular calcifications result from excess phosphate and calcium, as well as reduced activity of inhibitors of calcification, such as matrix Gla protein. Vitamin ...

A collaboration between researchers at FIU’s Herbert Wertheim College of Medicine (HWCOM) and the College of Engineering & Computing (CEC) has resulted in a U.S. patent that could eventually ...

Researchers from Tokyo Medical and Dental University (TMDU) have uncovered a link between cardiovascular disease and chronic kidney disease, revealing novel disease biomarkers and therapeutic targets ...